About the Authors

Madhav Thambisetty

thambisettym@mail.nih.gov

Affiliation Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, United States of America

Andrew Simmons

Affiliation King's College London, Institute of Psychiatry, London, United Kingdom

Abdul Hye

Affiliation King's College London, Institute of Psychiatry, London, United Kingdom

James Campbell

Affiliation Proteome Sciences plc, Coveham House, Cobham, United Kingdom

Eric Westman

Affiliation King's College London, Institute of Psychiatry, London, United Kingdom

Yi Zhang

Affiliation Department of Clinical Science, Intervention and Technology, Division of Radiology, Karolinska Institutet, Stockholm, Sweden

Lars-Olof Wahlund

Affiliation Department of Neurobiology, Care Sciences and Society, Section of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden

Anna Kinsey

Affiliation King's College London, Institute of Psychiatry, London, United Kingdom

Mirsada Causevic

Affiliation King's College London, Institute of Psychiatry, London, United Kingdom

Richard Killick

Affiliation King's College London, Institute of Psychiatry, London, United Kingdom

Iwona Kloszewska

Affiliation Department of Old Age Psychiatry and Psychotic Disorders, Medical University of Lodz, Lodz, Poland

Patrizia Mecocci

Affiliation Section of Gerontology and Geriatrics, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy

Hilkka Soininen

Affiliation Department of Neurology, University of Eastern Finland and University Hospital, Kuopio, Finland

Magda Tsolaki

Affiliation Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece

Bruno Vellas

Affiliation Department of Internal and Geriatrics Medicine, Hôpitaux de Toulouse, Toulouse, France

Christian Spenger

Affiliation Department of Clinical Science, Intervention and Technology, Division of Radiology, Karolinska Institutet, Stockholm, Sweden

Simon Lovestone

Affiliation Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, United States of America

for the AddNeuroMed consortium

Competing Interests

As detailed below, intellectual property has been registered on the use of plasma proteins for use as biomarkers for AD by King's College London and Proteome Sciences, with Drs. Lovestone, Campbell, and Thambisetty named as inventors. Dr. Campbell was a full-time employee of Proteome Sciences, London, U.K., at the time of his contribution to the work described in this manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Patent Title Methods and Compositions Relating to Alzheimer's Disease Subject Covers utility of around 30 proteins, specifically listing 16 in the Dependent claims for diagnosis of Alzheimer's disease Filing Proteome Sciences with King's Business UK Priority GB0421639.6 dated 29/09/2004 PCT Application PCT/GB2005/003756 dated 29/09/2005 Application in Europe, Japan, US, Australia, and Canada, dated 15/03/2007 to 16/10/2007.

Author Contributions

Conceived and designed the experiments: Madhav Thambisetty AS SL. Performed the experiments: Madhav Thambisetty AS AH AK MC RK. Analyzed the data: AS Madhav Thambisetty EW JC YZ. Contributed reagents/materials/analysis tools: L-OW IK PM HS Magda Tsolaki BV CS SL. Wrote the paper: Madhav Thambisetty AS SL.